Progress in the field of blood cancers has resulted in the rapid development of more effective, less toxic therapies. At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Rüdiger Hehlmann, MD, from Heidelberg University, Heidelberg, Germany, discusses some of the challenges posed by the rising cost of treatments.